^
    10d
    NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting (Businesswire)
    "NeoGenomics, Inc...will share its latest research on hematologic malignancies and the prognostic effects of microenvironment signatures in primary central nervous system (CNS) lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting, booth #2347, in San Diego, December 7-10. The company will also feature its robust hematological oncology solutions, including COMPASS, AML Express, and AML MRD Flow Panel."
    Clinical data
    |
    OncoCompass™ Target • AML Express™ • SafeSEQ AML MRD Assay
    2ms
    NeoGenomics launches AML express for rapid genetic profiling of Acute Myeloid Leukemia (NeoGenomics Press Release)
    "NeoGenomics, Inc...announced today the launch of AML Express, a next-generation sequencing (NGS) assay designed to provide rapid, comprehensive genetic profiling for patients with acute myeloid leukemia (AML)."
    Launch
    |
    AML Express™